GlaxoSmithKline News

Two experimental skin cancer drugs from GlaxoSmithKline - each designed to block different pathways used by tumour cells - look set to steal a march on Roche's pioneering melanoma treatment Zelboraf, according to Citigroup.

The city is the home of healthcare retailer Boots and has strong pharmacy and chemistry departments at the University of Nottingham which recently announced that GlaxoSmithKline was giving 12m for new sustainable chemistry laboratories.

GlaxoSmithKline Plc will reveal detailed results today on an experimental treatment for diabetes that's part of the reason for a $2.6 billion hostile takeover bid for Human Genome Sciences Inc.

Costco Wholesale Corporation : Baird raised its price target on Costco following Q3 results.

It was a case of all hands on deck for the 20 GlaxoSmithKline employees when they repainted Cathja in Isleworth.

GlaxoSmithKline may find its next acquisition target where the U.K. drugmaker found the last two: among more than a dozen companies it collaborates with to develop new treatments.

HOTBEDS Regional News US & Canada Biotech Bay Biotech Beach Genetown Pharm Country BioCapital BioMidwest Bio NC BioForest Southern Pharm BioCanada East US Device Europe Asia GlaxoSmithKline plc Wednesday, May 23, tweaked the terms of its hostile $2.59 billion offer for Human Genome Sciences Inc.

Drug Giants Such as AstraZeneca PLC , GlaxoSmithKline , Sanofi Join Forces With Academia on $285 Million Antibiotic Pact GlaxoSmithKline and AstraZeneca welcomed the launch of a pioneering approach to antibiotic research in Europe that will see pharmaceutical and biotechnology companies working alongside public partners to tackle the rising threat ... (more)

GlaxoSmithKline Plc may find its next acquisition target where the U.K. drugmaker found the last two: among more than a dozen companies it collaborates with to develop new treatments.

COPENHAGEN, Denmark, May 24, 2012 -- Genmab A/S announced today a milestone payment of DKK 20 million from GlaxoSmithKline to Genmab in connection with the filing of the New Drug Application to the Japanese Ministry of Health, Labor and Welfare .

GlaxoSmithKline shares move lower Wednesday as the firm modifies the terms of its $2.6 billion tender offer for Human Genome , which require that its quarry redeem or invalidate its poison pill.

Just last month GlaxoSmithKline was in the news for a move to acquire Human Genome Sciences , its partner of up to twenty years for $2.6 billion.

But the numbers for companies making the product for men are clear and direct, which is why Auxilium Pharmaceuticals Inc., of Malvern, Pa., and GlaxoSmithKline announced a deal Monday to try to sell more of Testim, Auxilium's prescription form of the gel.

Following GlaxoSmithKline's unsolicited $2.6-billion offer earlier this month for acquiring the biopharmaceutical company Human Genome Sciences , HGS announced late last week that its board of directors had unanimously determined that the offer of $13.00 per share undervalued HGS and issued a shareholder's rights plan advising stockholders to ... (more)

While we usually recommend using single-country funds as satellite holdings given their niche exposure, we think iShares MSCI United Kingdom Index is suitable as a core foreign-equity holding.

MALVERN, Pa., May 21, 2012 /PRNewswire/ -- Auxilium Pharmaceuticals, Inc. is raising its full year 2012 revenue guidance to a range of $293 to $315 million and is reducing its guidance for net loss to a range of $5 to $10 million.

Auxilium Pharmaceuticals, Inc. and GlaxoSmithKline entered into an agreement Monday to co-promote Testim, Auxilium's testosterone replacement therapy product used in adult males.

An interesting scenario is developing in the world of Sirius . For a while now, Liberty Media has been trying to gain control of Sirius XM.

Stiefel Laboratories has lost a $1.5 million jury verdict to a former employee who claimed the company bought back his stock at artificially low prices before its acquisition in 2009 by GlaxoSmithKline Timothy Finnerty won the judgment on May 16 in federal court in Miami against Stiefel and its former chief executive officer, Charles Stiefel.

Fifth Estate: Facebook's IPO, free education online, and the 'Obama Dashboard' In the Pipeline: Lobbying dollars in Harrisburg and an upcoming shale author event Science Fair has international flavor Renovations continue on Point State Park fountain New outdoor classroom opens at Children's Museum The task of finding the genetic roots of common ... (more)